Too often, patients with chronic kidney disease get diagnosed too late – if at all. Addressing risk factors early can stave ...

Novartis ( NYSE: NVS) said on Thursday that it received US FDA's accelerated approval for Vanrafia as a treatment for adults ...

A urine test strip method using the semi-quantitative albumin-to-creatinine ratio can enhance the early detection of chronic kidney disease in low-risk patients, a Belgian study finds.

African Americans face higher risks of kidney disease and endometriosis, yet awareness remains low. Learn key warning signs ...

A rare syndrome linked to purple urine reveals surprising insights into bacterial colonisation, metabolism, and risks for ...

Research led by Children's Hospital of Fudan University in China has found that a gene called pancreatic progenitor cell ...

The FDA granted accelerated approval to atrasentan (Vanrafia) for the reduction of proteinuria in adults with primary ...

Also read | World Kidney Day 2025: Hypertension and kidney disease, are they connected? Doctor explains symptoms, prevention tips World Kidney Day 2025: Here's how urine can help in spotting the first ...

Kidney disease and kidney failure is common amongst Texans. 76,126 Texans were living with end-stage renal disease in 2024, ...

When Novartis bought kidney disease biotech Chinook Therapeutics in 2023 for $3.2 billion upfront, the deal included a ...

which can eventually progress to kidney failure. Kidneys that have failed stop producing urine, which prevents the body from eliminating fluids. This causes electrolytes like potassium and ...